Head-to-head · Cost-Efficiency Index
TideMedix vs Oria Meds
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
TideMedix
Cost-first shoppers who want not recommended without calling to confirm the post-first-month price before signing up.
Visit TideMedixOria Meds
Readers who want the dispensing pharmacy named with an address and will complete the intake to see the real plan menu.
Visit Oria MedsThe verdict
TideMedix and Oria Meds tie on the Cost-Efficiency Index at 62/100, so neither wins outright on the numbers. For most shoppers we'd start with TideMedix (ranked #204, a hair above #209) — Cost-first shoppers who want not recommended without calling to confirm the post-first-month price before signing up. But Oria Meds is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs TideMedix.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | TideMedix | Oria Meds |
|---|---|---|
| Cost-Efficiency Index | 62/100 | 62/100 |
| Semaglutide / mo | $99/mo (compounded) | $199/month month-to-month (read in the intake; the homepage's $149 appears nowhere in the funnel) |
| Tirzepatide / mo | Not disclosed | $369/month month-to-month (the homepage's $249 appears nowhere in the funnel) |
| Semaglutide / yr (modeled) | $1,188 | $2,388 |
| Tirzepatide / yr (modeled) | — | $4,428 |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #204 | #209 |
TideMedix
62/100Where the value is
- Repeated, prominent LegitScript certification claims
- Low advertised entry price ($99) for the first month
- Standard FDA compounding disclaimer present, suggesting legitimate compounded-drug awareness
The tradeoffs
- Headline $99 price is explicitly first-month-only; the ongoing monthly cost is never disclosed on the site
- No named medical director anywhere in the accessible content
Oria Meds
62/100Where the value is
- Names its compounding pharmacy, PerfectRx, with a street address, phone number and website
- The monthly figure covers free shipping, a home injection kit, free dose increases and unlimited medical support, itemized on the plan card
- Names the provider network behind the prescriptions rather than referring only to licensed clinicians
The tradeoffs
- Neither published floor exists in the funnel: "starting at $149" and "starting at $249" appear nowhere in the plan menu, which offers $199 and $369
- The semaglutide ladder is inverted — one month is $199 while three and six months are both $209 a month, so committing longer costs more
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.